Home Abcam

Abcam

acquired
IPO Delisting
Developer of Life Science Reagents and Tools
Basic
Enterprise Profile

Basic Information

As an innovator in life science reagents and tools, Abcam, Inc. aims to serve life science researchers worldwide to help them achieve their missions more quickly. Two-thirds of the 750,000 life science researchers globally use Abcam's affinity binders, reagents, biomarkers, and assays.
Abcam, Inc.
Cambridge,England,United Kingdom
more than 500 people
January 01, 1998
--

Enterprise Profile

Industrial Sector
New Drug Development Medical Device R&D and Design
Concept
Tumor Immune System Diseases Laboratory Diagnosis
Application Scenarios
Innovative Drugs Low-Value Medical Consumables Medical Device Consumables